Intravenous immunoglobulins improve live birth rate among women with underlying immune conditions and recurrent pregnancy loss: a systematic review and meta-analysis

Intravenous immunoglobulin (IVIG) is increasingly used as a treatment for recurrent pregnancy loss (RPL) despite lack of clear evidence on efficacy. Recent data suggest IVIG might be more effective in a subgro...

Source: Allergy, Asthma and Clinical Immunology - March 11, 2022 Category: Allergy & Immunology Authors: Denise H. J. Habets, Kim Pelzner, Lotte Wieten, Marc E. A. Spaanderman, Eduardo Villamor and Salwan Al-Nasiry Tags: Review Source Type: research